Somerville, MA, United States of America

Evangelia Bellas

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Somerville, MA (US) (2016 - 2018)
  • Philadelphia, PA (US) (2023)

Company Filing History:


Years Active: 2016-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Evangelia Bellas: Innovator in Injectable Silk Fibroin Technologies

Introduction

Evangelia Bellas is a notable inventor based in Somerville, MA, who has made significant contributions in the field of biomaterials, particularly with her innovative work on injectable silk fibroin foams. With a total of three patents to her name, Bellas stands at the forefront of tissue repair and augmentation technologies.

Latest Patents

Bellas' latest inventions focus on the development of injectable silk fibroin compositions. One of her notable patents is for "Injectable silk fibroin foams and uses thereof," which describes methods, compositions, and delivery devices for minimally invasive tissue repairs. These compositions are designed to expand upon injection, filling tissue voids and providing scaffolding that facilitates tissue regeneration and reconstruction, specifically for soft tissue applications.

Another significant patent by Bellas is "Injectable silk fibroin particles and uses thereof." This invention pertains to injectable compositions that can be molded into various shapes and sizes for effective treatment of tissue voids. The silk fibroin particles maintain their volume within the tissue for a specified duration, enhancing both tissue repair and augmentation through flexible application.

Career Highlights

Bellas has been involved with prestigious institutions such as Tufts University and the University of Pittsburgh, where she has honed her research skills and contributed to groundbreaking developments in biomaterials.

Collaborations

Throughout her career, Bellas has collaborated with noteworthy colleagues, including David L. Kaplan and Gary G. Leisk. These collaborations have enriched her research and contributed to the progress of innovations in tissue engineering.

Conclusion

Evangelia Bellas continues to be a pioneering force in the development of injectable silk fibroin technologies, creating solutions that enhance tissue repair and support biomedical advancements. Her patented innovations are paving the way for improved treatment options in the field of tissue augmentation and reconstruction.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…